|
|
|
Research Papers
Biochemistry Department, University of Rochester, School of Medicine and Dentistry, Rochester, New York 14642.
Abstract
The transcriptional enhancer sequences of the papillomaviruses are regulated by trans-acting factors encoded by the viral E2 open reading frame. We have performed detailed functional and physical analyses of the enhancer of the human papillomavirus type 11 (HPV-11). Using the chloramphenicol acetyltransferase (CAT) assay in transiently transfected monkey CV-1 cells, the enhancer region has been localized to a 270-bp tract immediately preceding the E6 open reading frame, and it consists of two functional components. The first is a constitutive enhancer containing sequences homologous to the GT-, Sph-, and P-motifs found in the SV40 and polyomavirus enhancers; others resemble the recognition sequence for CTF (NF-1), a factor which stimulates transcription of certain eukaryotic genes and replication of adenovirus DNA. The second component is an inducible enhancer with a consensus sequence ACCN6GGT responsive to the E2 protein encoded by papillomaviruses. Tandem copies of portions of the constitutive enhancer function as an E2-independent enhancer, whereas multiple copies of HPV-11 DNA restriction fragments or synthetic oligonucleotides containing the E2-responsive sequence (E2-RS) act as an enhancer in the presence of the E2 protein encoded by HPV-1, HPV-11, or bovine papillomavirus type 1 (BPV-1). The inducible activity is lost when mutations are introduced into the E2-RS or when a mutant palindromic sequence is substituted. We have also expressed the E2 proteins of HPV-1, HPV-11, and BPV-1 in Escherichia coli and studied their physical interactions with the E2-responsive sequence in vitro. Filter-binding analyses with crude Escherichia coli lysates show that the E2 proteins bind to the E2-RS, but not to mutated motifs, with an affinity proportional to the copy number. These E2 proteins have been purified to near-homogeneity by sequence-specific DNA affinity chromatography using the synthetic E2-RS as a ligand. The purified proteins protect a DNA segment containing the E2-RS and several flanking nucleotides in pancreatic DNase I footprinting analyses. Based on these results, we conclude that E2 proteins activate the enhancer by binding directly to the E2-RS and interacting with other transcriptional factors and that the sequence ACCN6GGT is both necessary and sufficient for the E2 protein binding in vitro and for activation of RNA transcription in vivo.
This article has been cited by other articles:
![]() |
W. Deng, G. Jin, B.-Y. Lin, B. A. Van Tine, T. R. Broker, and L. T. Chow mRNA Splicing Regulates Human Papillomavirus Type 11 E1 Protein Production and DNA Replication J. Virol., October 1, 2003; 77(19): 10213 - 10226. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zou, B. Y. Lin, F. Duan, K.-Y. Lee, G. Jin, R. Guan, G. Yao, E. J. Lefkowitz, T. R. Broker, and L. T. Chow The Hinge of the Human Papillomavirus Type 11 E2 Protein Contains Major Determinants for Nuclear Localization and Nuclear Matrix Association J. Virol., April 15, 2000; 74(8): 3761 - 3770. [Abstract] [Full Text] |
||||
![]() |
S. Y. Hou, S.-Y. Wu, T. Zhou, M. C. Thomas, and C.-M. Chiang Alleviation of Human Papillomavirus E2-Mediated Transcriptional Repression via Formation of a TATA Binding Protein (or TFIID)-TFIIB-RNA Polymerase II-TFIIF Preinitiation Complex Mol. Cell. Biol., January 1, 2000; 20(1): 113 - 125. [Abstract] [Full Text] |
||||
![]() |
V. K. Gadi, N. Zou, J.-S. Liu, S. Cheng, T. R. Broker, E. J. Sorscher, and L. T. Chow Components of Human Papillomavirus That Activate Transcription and Support Plasmid Replication in Human Airway Cells Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 1001 - 1006. [Abstract] [Full Text] |
||||
![]() |
K. L. Conger, J.-S. Liu, S.-R. Kuo, L. T. Chow, and T. S.-F. Wang Human Papillomavirus DNA Replication. INTERACTIONS BETWEEN THE VIRAL E1 PROTEIN AND TWO SUBUNITS OF HUMAN DNA POLYMERASE alpha /PRIMASE J. Biol. Chem., January 29, 1999; 274(5): 2696 - 2705. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stubenrauch, H. B. Lim, and L. A. Laimins Differential Requirements for Conserved E2 Binding Sites in the Life Cycle of Oncogenic Human Papillomavirus Type 31 J. Virol., February 1, 1998; 72(2): 1071 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Leask, M Rosenberg, R Vassar, and E Fuchs Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription. Genes & Dev., November 1, 1990; 4(11): 1985 - 1998. [Abstract] [PDF] |
||||
![]() |
A Stenlund and M R Botchan The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes & Dev., January 1, 1990; 4(1): 123 - 136. [Abstract] [PDF] |
||||
![]() |
R Li, J Knight, G Bream, A Stenlund, and M Botchan Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes & Dev., April 1, 1989; 3(4): 510 - 526. [Abstract] [PDF] |
||||
![]() |
P F Lambert, N Dostatni, A A McBride, M Yaniv, P M Howley, and B Arcangioli Functional analysis of the papilloma virus E2 trans-activator in Saccharomyces cerevisiae. Genes & Dev., January 1, 1989; 3(1): 38 - 48. [Abstract] [PDF] |
||||